| Literature DB >> 34940609 |
Elena Legrand1, Niladri Basu1, Markus Hecker2, Doug Crump3, Jianguo Xia1, Bharat Chandramouli4, Heather Butler4, Jessica A Head1.
Abstract
This proof-of-concept study characterizes the Japanese quail (Coturnix japonica) hepatic metabolome following exposure to benzo[a]pyrene, chlorpyrifos, ethinylestradiol, fluoxetine hydrochloride, hexabromocyclododecane, lead(II)nitrate, seleno-L-methionine, and trenbolone in embryos and adults. The analysis revealed effects on lipid metabolism following exposure to several chemicals at both life stages. The most pronounced effects were observed in embryos exposed to 41.1 μg/g chlorpyrifos. This work highlighted challenges and the need for further avian metabolomics studies.Entities:
Keywords: LC-MS; avian; early life stage; environmental metabolomics; mass spectrometry
Year: 2021 PMID: 34940609 PMCID: PMC8715744 DOI: 10.3390/metabo11120850
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Experimental design of the early-life stage (ELS) and adult Japanese quail exposures, adapted from Farhat et al. [13] and Boulanger et al. [14]. ELS and adult Japanese quail were exposed to 8 environmental chemicals (benzo[a]pyrene (BaP), chlorpyrifos (CPF), ethinylestradiol (EE2), fluoxetine hydrochloride (FLX), hexabromocyclododecane (HBCD), lead(II)nitrate (Pb), seleno-L-methionine (SeMe), and trenbolone (TB)) following this experimental design. (A) Embryos were exposed via egg injection on day 0 of incubation. A subset was euthanized on embryonic day 9 and liver samples were taken for omics and chemical residue analysis. To provide sufficient tissue for metabolomics, 3–4 ELS livers were pooled for each replicate (n = 3 replicates). Remaining embryos were incubated until embryonic day 16 in order to monitor apical outcomes. (B) Adults were exposed to a single dose via gavage. A subset was euthanized 4 days later for omics (n = 5) and chemical residue analysis. Remaining individuals were maintained until day 14 in order to monitor apical outcomes.
Figure 2Principal component analysis (PCA) scores plot of the early-life stage (ELS) Japanese quail (JQ) liver metabolome after exposure to chlorpyrifos (CPF, A), trenbolone (TB, B), fluoxetine (FLX, C), benzo(a)pyrene (BaP, D), ethinylestradiol (EE2, E), hexabromocyclodecane (HBCD, F), lead(II)nitrate (Pb, G), and seleno-L-methionine (SeMe, H). JQ were exposed to three doses defined as low dose (LD, dark blue), medium dose (MD, green), and high dose (HD, red).
Most-impacted (log2Fold Change > |1.5|) metabolites by chemical treatment in early-life stage and adult Japanese quail liver. Statistically significant metabolites were identified by one-way ANOVA and Tukey post hoc (false discovery rate FDR < 0.05). The full list of metabolites statistically different between treated and control groups is reported in Table S1. For better visibility, some metabolites were abbreviated: phosphatidylcholine diacyl (PC aa) and phosphatidylcholine acyl-alkyl (PC ae).
| Life Stage | Chemical | Doses | Metabolite Class | Metabolite | FDR | Log2(FC) | |||
|---|---|---|---|---|---|---|---|---|---|
| HD | MD | LD | |||||||
| ELS | CPF | HD | ABA | Ornithine | 1.00 × 10−2 | 2.87 × 10−2 | −1.62 | ||
| HD | FHB | Arachidonic acid | 7.54 × 10−3 | 2.22 × 10−2 | −1.82 | ||||
| HD | Docosahexaenoic acid | 2.07 × 10−2 | 4.65 × 10−2 | −3.45 | |||||
| HD | FA C22:5n6c | 1.11 × 10−2 | 2.96 × 10−2 | −4.64 | |||||
| MD | LIP | AC C14 | 1.04 × 10−2 | 2.87 × 10−2 | 3.25 | ||||
| MD | AC C16 | 4.99 × 10−3 | 1.70 × 10−2 | 1.90 | |||||
| MD | AC C18:1 | 3.97 × 10−4 | 4.32 × 10−3 | 2.01 | |||||
| MD | AC C18:2 | 3.44 × 10−5 | 1.14 × 10−3 | 2.95 | |||||
| HD | lysoPC a C18:1 | 2.04 × 10−3 | 1.06 × 10−2 | 1.63 | |||||
| HD | lysoPC a C18:2 | 5.92 × 10−3 | 1.87 × 10−2 | 1.60 | |||||
| HD | PC aa C32:2 | 3.36 × 10−4 | 4.29 × 10−3 | 1.76 | |||||
| HD | PC aa C34:1 | 2.07 × 10−4 | 3.01 × 10−3 | 1.56 | |||||
| HD | PC aa C34:2 | 8.09 × 10−4 | 6.71 × 10−3 | 1.71 | |||||
| HD | PC aa C34:3 | 2.76 × 10−3 | 1.17 × 10−2 | 1.82 | |||||
| HD | PC aa C36:1 | 1.16 × 10−5 | 4.83 × 10−4 | 1.85 | |||||
| HD | PC aa C36:2 | 7.35 × 10−5 | 2.03 × 10−3 | 1.90 | |||||
| HD | PC aa C36:3 | 5.05 × 10−4 | 4.65 × 10−3 | 1.62 | |||||
| HD | PC ae C42:2 | 1.59 × 10−3 | 9.25 × 10−3 | 2.04 | |||||
| HD | PC ae C42:4 | 4.16 × 10−4 | 4.32 × 10−3 | −2.04 | |||||
| HD;MD;LD | SM C26:1 | 1.89 × 10−3 | 1.01 × 10−2 | −3.07 | −2.27 | −2.73 | |||
| EE2 | HD;MD;LD | LIP | PC aa C40:2 | 2.23 × 10−7 | 3.71 × 10−5 | −2.60 | −2.34 | −2.74 | |
| Adult | TB | HD; MD; LD | ABA | Asymmetric | 6.99 × 10−5 | 5.15 × 10−3 | 1.66 | 1.95 | 1.90 |
| Pentose- | 6.10 × 10−4 | 2.69 × 10−2 | −2.43 | −2.83 | −2.62 | ||||
Chemicals are defined as follows: chlorpyrifos (CPF), ethinylestradiol (EE2), and trenbolone (TB), and the doses as high dose (HD), medium dose (MD), and low dose (LD).
Metabolites impacted by multiple chemicals in early-life stage (ELS) and adult quail. None of the metabolites were impacted at both life stages. Chemicals are abbreviated as chlorpyrifos (CPF), ethinylestradiol (EE2), trenbolone (TB), and seleno-L-methionine (SeMe).
| Metabolite | Chemicals | Life Stage |
|---|---|---|
| PC ae C36:2 | CPF, EE2 | ELS |
| PC aa C34:1 | CPF, EE2 | ELS |
| PC aa C34:2 | CPF, EE2 | ELS |
| PC aa C36:1 | CPF, EE2 | ELS |
| PC aa C36:2 | CPF, EE2 | ELS |
| PC ae C38:6 | FLX, SeMe | Adult |
Administered concentrations of test chemicals in early-life stage (ELS) and adult Japanese quail. As described in Figure 1, ELS Japanese quail were injected with a single chemical dose, while adult Japanese quail were exposed via gavage. Vehicle solvents were DMSO and corn oil for ELS and adult, respectively. Values in the table were calculated based on the analytically determined (ELS) or nominal (adult) concentrations of the dosing solutions. Chemicals are abbreviated as follows: ethinylestradiol (EE2), chlorpyrifos (CPF), benzo[a]pyrene (BaP), lead(II)nitrate (Pb), seleno-L-methionine (SeMe), fluoxetine hydrochloride (FLX), trenbolone (TB), and hexabromocyclododecane (HBCD). JQ were exposed to three doses of each chemical (low dose: LD, medium dose: MD, and high dose: HD). Table was adapted from Farhat et al. [13] and Boulanger et al. [14].
| Chemical | ELS | Adult | ||||
|---|---|---|---|---|---|---|
| Administered Concentration | Administered Concentration | |||||
| LD | MD | HD | LD | MD | HD | |
| EE2 | 0.54 | 6.3 | 54.2 | 0.05 | 0.5 | 5 |
| CPF | 0.56 | 4.9 | 41.1 | 0.1 | 1 | 10 |
| BaP | 0.01 | 0.05 b | 0.83 | 0.5 | 5 | 50 |
| Pb | 0.07 c (0.11) | 0.7 c (1.1) | 6.7 (10.7) | 35 | 350 | 3500 |
| SeMe | 0.0003 d (0.0007) | 0.002 d (0.005) | 0.03 d (0.07) | 0.1 | 1 | 10 |
| FLX | 0.39 | 4.6 | 32.7 | 1 | 10 | 100 |
| TB | 0.04 | 0.43 | 4.4 | 0.1 | 1 | 10 |
| HBCD | 0.02γ | 0.73γ | 10.5γ | 10 | 100 | 1000 |
a: Parts per million relative to egg and body weight for ELS and adult Japanese quail, respectively. b: Nominal value (due to an error, this stock solution was not analyzed). c,d: Reported values represent the analytically determined concentrations of elemental lead or selenium, followed by the calculated concentrations of lead(II)nitrate or seleno-L-methionine in parentheses, where applicable. γ: γ-HBCD is the predominant isomer in the technical mixture used in this study.